GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.

What symbol and exchange does Glucotrack shares trade?

Glucotrack trades on the NASDAQ stock market under the symbol GCTK.

What is Glucotrack stock price doing today?

As of October 22, 2026, GCTK stock price declined to $0.59 with 51,039 million shares trading.

What is Glucotrack's Beta?

GCTK has a beta of 2.45, meaning it tends to be more sensitive to market movements. GCTK has a correlation of 0.04 to the broad based SPY ETF.

How much is Glucotrack worth?

GCTK has a market cap of $600,630.00. This is considered a Sub-Micro Cap stock.

What is the highest and lowest price Glucotrack traded in the last 3 year period?

In the last 3 years, GCTK traded as high as $89,099.98 and as low as $.56.

Is Glucotrack (GCTK) a good investment?

GCTK has underperformed the market in the last year with a price return of -99.4% while the SPY ETF gained +15.0%. GCTK has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -89.5% and -48.7%, respectively, while the SPY returned +2.4% and -1.6%, respectively.

What are the support and resistance levels for Glucotrack (GCTK)?

GCTK support price is $.56 and resistance is $.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GCTK shares will trade within this expected range on the day.